<DOC>
	<DOCNO>NCT01494571</DOCNO>
	<brief_summary>The PharmaJet needle-free injection system consistent approach deliver injectates dermal layer human skin purpose vaccination medication delivery .</brief_summary>
	<brief_title>Pediatric Optimization PharmaJet Needle-Free Intradermal Delivery System</brief_title>
	<detailed_description>Up 400 child , age 2 month 14 year 1 . To assess measure injection performance , include estimate injection completeness collect residual surface moisture filter paper circle indelible ink ; volume compare reference set moisture recording . 2 . To document completeness injection ; completeness define &lt; 10 % 0.1 ml volume remain skin surface immediately injection . Measurement bleb size follow injection record millimeter . 3 . To ensure device well received subject . Subject 's response injection note subject and/or family member procedure 48 hour .</detailed_description>
	<criteria>Infants child age 2 month 14 year Outpatient , expect go home day surgery Written consent assent appropriate Willing complete return pain diary ( postcard ) 48 hour Presently skin rash intend injection site Have history use topical systemic medication intend injection site could potentially alter normal physical property skin ( i.e . atrophy chronic steroid use , thin skin topical systemic retinoids ) . Have permanent physical change skin intend injection site , burn , scar prior radiation therapy . Skin disorder may predispose develop skin lesion sit trauma . Present use blood thin medication . In 1011 year old cohort , none participant start puberty .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>